We have launched our mobile app, get it now. Call : 9354229384, 9354252518, 9999830584.  

Tags Current Affairs

Pfizer’s Covid vaccine approval for adolescents

Date: 05 May 2021 Tags: Miscellaneous

Issue

Pfizer-BioNTech vaccine is set to be given approval by regulators in Europe and US for using against adolescents between ages 12-15.

 

Background

The Pfizer-BioNTech vaccine is currently in use after getting emergency approval against individuals above the age of 16 years.

 

Details

  • The manufacturers have said that their vaccine provides an efficiency of 100 percent for individuals within the tested age group of 12-15 years.

  • In individuals within age of 12-15 years with or without prior SARS CoV-2 has also demonstrated a 100 percent efficacy that included robust anti-body response.

 

Status of vaccination

  • Moderna, Pfizer-BioNTech and Johnson & Johnson vaccines have been authorised to be used under emergency approval.

  • About 31 percent of US population have been completely vaccinated whereas about 44.4 percent of them have been given at least a single dose.

  • Vaccine hesitancy is expected to reduce the speed of vaccination. Among the citizens, black Americans and Republicans are most likely to be hesitant to take vaccine.

  • This could be a reason for US not achieving herd immunity in near future. The mutated virus strain has also delayed herd immunity.

  • EU too has been aggressively conducting vaccination program for its citizens. Issues such as delay in delivery of vaccine are hampering the process of vaccination.

  • EU had also initiated legal action against vaccine manufacturer AstraZeneca for failing to deliver promised amount of vaccines.

Notice (8): Undefined variable: quizpole [ROOT/plugins/Studyiq/src/Template/Pages/tagdetails.ctp, line 161]